2025 BIO International Recap
June 19, 2025
BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in Boston, MA. drew appproximately 20,000 attendees. The Utah delegation included BioUtah, Utah life sciences companies, the Governor’s Office of Economic Development, the Unversity of Utah’s Technology Licensing Office, EDCUtah and the Utah World Trade Center. The Pavillion provided an exceptional opportunity to showcase Utah’s dynamic biotech community to a large audience from across the nation and across the globe.
“The conference provided a forum to raise the profile of Utah’s growing pharma sector and make valuable connections,” said Kelvyn Cullimore, president and CEO of BioUtah, who was on hand for the event. “The sessions provided insights on relevant topics and the Utah exhibit helped broadcast to conference-goers our innovation story.”
A number of Utah companies in attendance included:
- Halia Therapeutics
- Biolexis Therapeutics
- Curza
- Clene Nanomedicine
- Renew Biotechnologies
- 3Helix
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
